Healthcare provider profile · identity verified

John Varkey Puthenveetil, MD

Cardiology · ROCKY MOUNT, NC · NPI 1639146897

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	577	152
Atorvastatin Calcium	Atorvastatin Calcium	446	111
Furosemide	Furosemide	274	72
Lisinopril	Lisinopril	256	61
Hydrochlorothiazide	Hydrochlorothiazide	246	72
Metoprolol Succinate	Metoprolol Succinate	212	58
Hydralazine Hcl	Hydralazine Hcl	207	52
Metformin Hcl	Metformin Hcl	204	61
Rosuvastatin Calcium	Rosuvastatin Calcium	185	48
Metoprolol Tartrate	Metoprolol Tartrate	182	41
Losartan Potassium	Losartan Potassium	178	56
Gabapentin	Gabapentin	177	47
Meloxicam	Meloxicam	172	39
Levothyroxine Sodium	Levothyroxine Sodium	169	44
Omeprazole	Omeprazole	169	50
Potassium Chloride	Potassium Chloride	160	42
Pantoprazole Sodium	Pantoprazole Sodium	158	49
Clonidine Hcl	Clonidine Hcl	129	27
Simvastatin	Simvastatin	127	32
Alprazolam	Alprazolam	124	26
Eliquis	Apixaban	109	28
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	106	26
Glipizide	Glipizide	102	27
Albuterol Sulfate Hfa	Albuterol Sulfate	95	34
Carvedilol	Carvedilol	92	22
Allopurinol	Allopurinol	90	27
Montelukast Sodium	Montelukast Sodium	82	21
Valsartan	Valsartan	80	20
Clopidogrel	Clopidogrel Bisulfate	77	20
Famotidine	Famotidine	69	21
Lorazepam	Lorazepam	68	suppressed
Spironolactone	Spironolactone	68	14
Ozempic	Semaglutide	66	11
Methylprednisolone	Methylprednisolone	65	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	21
Donepezil Hcl	Donepezil Hcl	59	suppressed
Mirtazapine	Mirtazapine	59	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	19
Trazodone Hcl	Trazodone Hcl	57	24
Tamsulosin Hcl	Tamsulosin Hcl	54	19
Benazepril Hcl	Benazepril Hcl	53	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	25
Meclizine Hcl	Meclizine Hcl	50	21
Pravastatin Sodium	Pravastatin Sodium	50	18
Ibuprofen	Ibuprofen	47	20
Tizanidine Hcl	Tizanidine Hcl	47	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	11
Metformin Hcl Er	Metformin Hcl	44	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	11
Ezetimibe	Ezetimibe	39	11
Fluticasone Propionate	Fluticasone Propionate	39	15
Jardiance	Empagliflozin	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	11
Alendronate Sodium	Alendronate Sodium	34	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Linzess	Linaclotide	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Baclofen	Baclofen	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	11
Azithromycin	Azithromycin	29	29
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Prednisone	Prednisone	28	suppressed
Ramipril	Ramipril	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	11
Nifedipine Er	Nifedipine	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Lactulose	Lactulose	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	15
Sucralfate	Sucralfate	20	12
Finasteride	Finasteride	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Nateglinide	Nateglinide	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	13
Nitroglycerin	Nitroglycerin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Colchicine	Colchicine	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Cephalexin	Cephalexin	14	13
Tradjenta	Linagliptin	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Paricalcitol	Paricalcitol	13	suppressed
Pen Needles	Pen Needle, Diabetic	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Topiramate	Topiramate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error